Hyperthermic Intraperitoneal Chemotherapy for Treatment of Ovarian and Primary Peritoneal Malignancies: Single Institutional Experience

Volume: 3, Issue: 2, Pages: 53 - 59
Published: Jan 8, 2016
Abstract
Objective: To report our institutional experience onhyperthermicintraperitoneal chemotherapy (HIPEC) at the time of cytoreductive surgery (CRS) for ovarian, fallopian tube and primary peritoneal cancer. null null Methods: We reviewed charts of patients who underwent CRS and HIPEC. Optimal cytoreduction was defined as residual disease null < null 1cm. HIPEC was administered using closed technique. The postoperative complications were graded using...
Paper Details
Title
Hyperthermic Intraperitoneal Chemotherapy for Treatment of Ovarian and Primary Peritoneal Malignancies: Single Institutional Experience
Published Date
Jan 8, 2016
Volume
3
Issue
2
Pages
53 - 59
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.